Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             395 results found
no title author magazine year volume issue page(s) type
1 Acute treatment with pentobarbital alters the kinetics of in vivo receptor binding in the mouse brain Sakiyama, Yojiro
2006
72-73 4 p. 535-541
7 p.
article
2 A facile method for the labeling of proteins with zirconium isotopes Meijs, Wilma E.
1996
72-73 4 p. 439-448
10 p.
article
3 A facile synthesis of radioiodinated (Z)-vinyl iodides via vinylboronates Kabalka, George W.
2003
72-73 4 p. 369-372
4 p.
article
4 Amino- and amido-tetrabenazine derivatives: Synthesis and evaluation as potential ligands for the vesicular monoamine transporter Canney, Daniel J.
1995
72-73 4 p. 527-535
9 p.
article
5 An allogenic site-specific rat model of bone metastases for nuclear medicine and experimental oncology Biesalski, Barbara
2012
72-73 4 p. 502-508
7 p.
article
6 Analysis of blood clearance and labeled metabolites for the estrogen receptor tracer [F-18]-16α-Fluorestradiol (FES) Mankoff, David A.
1997
72-73 4 p. 341-348
8 p.
article
7 Analysis of residual solvents in 2-[18F]FDG by GC Channing, Michael A
2001
72-73 4 p. 469-471
3 p.
article
8 An automated module for the separation and purification of cyclotron-produced 99mTcO4 − Morley, Thomas J.
2012
72-73 4 p. 551-559
9 p.
article
9 An automated one-step one-pot [18F]FCWAY synthesis: development and minimization of chemical impurities Vuong, Bik-Kee
2007
72-73 4 p. 433-438
6 p.
article
10 An automatic MRI/SPECT registration algorithm using image intensity and anatomical feature as matching characters: application on the evaluation of Parkinson's disease Lee, Jiann-Der
2007
72-73 4 p. 447-457
11 p.
article
11 A new nucleophilic fluorine-18 labeling method for aliphatic mesylates: reaction in ionic liquids shows tolerance for water Kim, Dong Wook
2003
72-73 4 p. 345-350
6 p.
article
12 An improved kit formulation of a dopamine transporter imaging agent: [Tc-99m]TRODAT-1 Choi, S.R
1999
72-73 4 p. 461-466
6 p.
article
13 An improved method for the synthesis of radiolabeled McN5652 via thioester precursors Suehiro, Makiko
1995
72-73 4 p. 543-545
3 p.
article
14 Announcement 1994
72-73 4 p. I-
1 p.
article
15 Antilipolytic drug boosts glucose metabolism in prostate cancer Andersen, Kim Francis
2013
72-73 4 p. 524-528
5 p.
article
16 A pet study of adenosine A1 receptor in anesthetized monkey brain Wakabayashi, Shin-ichi
2000
72-73 4 p. 401-406
6 p.
article
17 Apoptosis and p53 are not involved in the anti-tumor efficacy of 125I-labeled monoclonal antibodies targeting the cell membrane Paillas, Salomé
2013
72-73 4 p. 471-480
10 p.
article
18 A Potential imaging agent for the GABAA receptor: 4-t-butyl-1-(4-[123I]iodophenyl)-2, 6,7-trioxabicyclo-[2.2.2]octane Culbert, Paul A.
1993
72-73 4 p. 469-475
7 p.
article
19 Application of highly sensitive UPLC–MS to determine biodistribution at tracer doses: validation with the 5-HT1A ligand [18F]FPWAY Ma, Ying
2009
72-73 4 p. 389-393
5 p.
article
20 A preliminary PET evaluation of the new dopamine D2 receptor agonist [11C]MNPA in cynomolgus monkey Finnema, Sjoerd J.
2005
72-73 4 p. 353-360
8 p.
article
21 Aptamers as radiopharmaceuticals for nuclear imaging and therapy Gijs, Marlies
2016
72-73 4 p. 253-271
19 p.
article
22 A radioimmunoimaging and MIRD dosimetry treatment planning program for radioimmunotherapy Erwin, William D.
1996
72-73 4 p. 525-532
8 p.
article
23 Asialoglycoprotein-receptor-targeted hepatocyte imaging using 99mTc galactosylated chitosan Kim, Eun-Mi
2006
72-73 4 p. 529-534
6 p.
article
24 A simple and efficient in vitro method for metabolism studies of radiotracers Lee, Sang-Yoon
2001
72-73 4 p. 391-395
5 p.
article
25 A simplified suite of methods to evaluate chelator conjugation of antibodies: effects on hydrodynamic radius and biodistribution Al-Ejeh, Fares
2009
72-73 4 p. 395-402
8 p.
article
26 Aspects of 6-[18F]fluoro-L-DOPA preparation: precursor synthesis, preparative HPLC purification and determination of radiochemical purity Füchtner, F.
2002
72-73 4 p. 477-481
5 p.
article
27 Astatine-211 labeling of internalizing anti-EGFRvIII monoclonal antibody using N-succinimidyl 5-[211At]astato-3-pyridinecarboxylate Reist, Craig J
1999
72-73 4 p. 405-411
7 p.
article
28 A strategy for increasing the brain uptake of a radioligand in animals: use of a drug that inhibits plasma protein binding Haradahira, Terushi
2000
72-73 4 p. 357-360
4 p.
article
29 Automated production of 16α-[18F]fluoroestradiol for breast cancer imaging Römer, J
1999
72-73 4 p. 473-479
7 p.
article
30 Automated synthesis and PET evaluation of both enantiomers of [18F]FMISO Revunov, Evgeny
2015
72-73 4 p. 413-419
7 p.
article
31 Automated synthesis of 11β-methoxy-4,16α-[16α-18F]difluoroestradiol (4F-M[18F]FES) for estrogen receptor imaging by positron emission tomography Ahmed, Naseem
2007
72-73 4 p. 459-464
6 p.
article
32 Back-to-back “one-pot” [18F]FDG syntheses in a single Siemens-CTI chemistry process control unit Mock, Bruce H.
1996
72-73 4 p. 497-501
5 p.
article
33 Binding characteristics of 9-fluoropropyl-(+)-dihydrotetrabenzazine (AV-133) to the vesicular monoamine transporter type 2 in rats Tsao, Hsin-Hsin
2010
72-73 4 p. 413-419
7 p.
article
34 Binding of 2-[18F]fluoro-CP-118,954 to mouse acetylcholinesterase: microPET and ex vivo Cerenkov luminescence imaging studies Kim, Dong Hyun
2011
72-73 4 p. 541-547
7 p.
article
35 Biodistribution and tumor localization of 111In-labeled unmodified and modified F(ab′)2 fragments of human monoclonal IgM (16.88) in a nude mouse model Quadri, Syed M.
1995
72-73 4 p. 413-423
11 p.
article
36 Biodistribution of adult derived human liver stem cells following intraportal infusion in a 17-year-old patient with glycogenosis type 1A Defresne, Florence
2014
72-73 4 p. 371-375
5 p.
article
37 Biodistribution of anti-CEA F(ab′)2 fragments conjugated with chelating polymers: Influence of conjugate electron charge on tumor uptake and blood clearance Slinkin, M.A.
1993
72-73 4 p. 443-452
10 p.
article
38 Biodistribution, pharmacokinetics and imaging of 188Re-BMEDA-labeled pegylated liposomes after intraperitoneal injection in a C26 colon carcinoma ascites mouse model Chen, Liang-Cheng
2007
72-73 4 p. 415-423
9 p.
article
39 bis-benzimidazole dyes, Hoechst 33258 and Hoechst 33342: Radioiodination, facile purification and subcellular distribution Harapanhalli, Ravi S.
1994
72-73 4 p. 641-647
7 p.
article
40 Blocking [211At]Astatide Accumulation in Normal Tissues: Preliminary Evaluation of Seven Potential Compounds Larsen, Roy H
1998
72-73 4 p. 351-357
7 p.
article
41 Bombesin analogues for gastrin-releasing peptide receptor imaging Nanda, Prasant K.
2012
72-73 4 p. 461-471
11 p.
article
42 Can celecoxib affect P-glycoprotein-mediated drug efflux? A microPET study de Vries, Erik F.J.
2008
72-73 4 p. 459-466
8 p.
article
43 Candidate PET radioligands for cannabinoid CB1 receptors: [18F]AM5144 and related pyrazole compounds Li, Zizhong
2005
72-73 4 p. 361-366
6 p.
article
44 Carbon-11-labeled estrogens as potential imaging agents for breast tumors Dence, Carmen S.
1996
72-73 4 p. 491-496
6 p.
article
45 Carbon-11 labeled papaverine as a PET tracer for imaging PDE10A: radiosynthesis, in vitro and in vivo evaluation Tu, Zhude
2010
72-73 4 p. 509-516
8 p.
article
46 Cellular Distribution of 111In-LDTPA Galactose BSA in Normal and Asialoglycoprotein Receptor-Deficient Mouse Liver Deal, Kim A
1998
72-73 4 p. 379-385
7 p.
article
47 Cellular metabolic responses of PET radiotracers to 188Re radiation in an MCF7 cell line containing dominant-negative mutant p53 Cheon, Gi Jeong
2007
72-73 4 p. 425-432
8 p.
article
48 Cerebral kinetics of the dopamine D2 receptor ligand [123I]IBZM in mice Meyer, Philipp T.
2008
72-73 4 p. 467-473
7 p.
article
49 Characterization, biodistribution and small-animal SPECT of I-125-labeled c-Met binding peptide in mice bearing c-Met receptor tyrosine kinase-positive tumor xenografts Kim, Eun-Mi
2009
72-73 4 p. 371-378
8 p.
article
50 Characterization of R-[11C]rolipram for PET imaging of phosphodiesterase-4: in vivo binding, metabolism, and dosimetry studies in rats Lourenco, Celia M
2001
72-73 4 p. 347-358
12 p.
article
51 11C-harmine as a tracer for monoamine oxidase a (MAO-A): In vitro and in vivo studies Bergström, Mats
1997
72-73 4 p. 287-293
7 p.
article
52 Chemical fate of the nicotinic acetylcholinergic radiotracer [123I]5-IA-85380 in baboon brain and plasma Baldwin, Ronald M.
2006
72-73 4 p. 549-554
6 p.
article
53 Chimeric anti-tenascin antibody 81C6: Increased tumor localization compared with its murine parent Zalutsky, Michael R.
1996
72-73 4 p. 449-458
10 p.
article
54 Combined-modality radioimmunotherapy: synergistic effect of paclitaxel and additive effect of bevacizumab Jang, Beom-Su
2012
72-73 4 p. 472-483
12 p.
article
55 Combined use of 111in-DTPA-D-Phe-1-octreotide (OCT) and 123I-vasoactive intestinal peptide (VIP) in the localization diagnosis of medullary thyroid carcinoma (MTC) Kurtaran, Amir
1996
72-73 4 p. 503-507
5 p.
article
56 Comparative tissue distribution of conformationally restricted radioiodinated vesamicol receptor ligands Efange, S.M.N.
1995
72-73 4 p. 437-444
8 p.
article
57 Comparative uptake of polyamines by prostate and non-prostate cancer cell lines Srinath, P.
2002
72-73 4 p. 497-503
7 p.
article
58 Comparison of conventional and novel PET tracers for imaging mesothelioma in nude mice with subcutaneous and intrapleural xenografts Tsuji, Atsushi B.
2009
72-73 4 p. 379-388
10 p.
article
59 Comparison of in vivo dopamine D2 receptor binding of [123I]AIBZM and [123I]IBZM in rat brain Li, Hongfeng
2001
72-73 4 p. 383-389
7 p.
article
60 Comparison of 99mTc-TRODAT-1 SPECT and 18 F-AV-133 PET imaging in healthy controls and Parkinson’s disease patients Hsiao, Ing-Tsung
2014
72-73 4 p. 322-329
8 p.
article
61 Comparison of the Kit Performance of Three 99mTc Myocardial Perfusion Agents Cagnolini, Aldo
1998
72-73 4 p. 435-439
5 p.
article
62 Contents 2008
72-73 4 p. IBC-
1 p.
article
63 Contents 2010
72-73 4 p. IBC-
1 p.
article
64 Convenient gas phase bromination of [11C]methane and production of [11C]methyl triflate Mock, Bruce H
1999
72-73 4 p. 467-471
5 p.
article
65 Copper-64-diacetyl-bis (N 4-methylthiosemicarbazone) accumulates in rich regions of CD133+ highly tumorigenic cells in mouse colon carcinoma Yoshii, Yukie
2010
72-73 4 p. 395-404
10 p.
article
66 Corrigendum to "Synthesis, Characterization and Theranostic Evaluation of Indium-111 labeled Multifunctional Superparamagnetic Iron Oxide Nanoparticles" 2015
72-73 4 p. 420-
1 p.
article
67 Corticotropin releasing hormone and imaging, rethinking the stress axis Contoreggi, Carlo
2015
72-73 4 p. 323-339
17 p.
article
68 [11C]palmitate kinetics across the splanchnic bed in arterial, portal and hepatic venous plasma during fasting and euglycemic hyperinsulinemia Guiducci, Letizia
2006
72-73 4 p. 521-528
8 p.
article
69 [11C]Sorafenib: Radiosynthesis and preclinical evaluation in tumor-bearing mice of a new TKI-PET tracer Poot, Alex J.
2013
72-73 4 p. 488-497
10 p.
article
70 [64Cu]diacetyl-bis(N 4-methyl-thiosemicarbazone) — a radiotracer for tumor hypoxia Wood, Katie A.
2008
72-73 4 p. 393-400
8 p.
article
71 Cyclic and acyclic polyamines as chelators of rhenium-186 and Rhenium-188 for therapeutic use Prakash, Sushumna
1996
72-73 4 p. 543-549
7 p.
article
72 Cysteine, a chelating moiety for synthesis of technetium-99m radiopharmaceuticals—Part IV. Benzyl cysteine and derivatives Mukherjee, Soma
1993
72-73 4 p. 413-426
14 p.
article
73 David James Silvester, Ph.D. 1932–2013 Thakur, Mathew L.
2013
72-73 4 p. 443-444
2 p.
article
74 Decomposition of an aqueous solution of [11C]Ro 15-4513: implication of hydrated electrons in the radiolysis of [11C]Ro 15-4513 Fukumura, Toshimitsu
2003
72-73 4 p. 389-395
7 p.
article
75 Delivery of the α-emitting radioisotope bismuth-213 to solid tumors via single-chain Fv and diabody molecules Adams, G.P
2000
72-73 4 p. 339-346
8 p.
article
76 Demonstration of dose dependent cytotoxic activity in SW480 colon cancer cells by 177Lu-labeled siRNA targeting IGF-1R Fathi, Mojtaba
2013
72-73 4 p. 529-536
8 p.
article
77 Design and biological evaluation of 99mTc-N2S2-Tat(49–57)-c(RGDyK): A hybrid radiopharmaceutical for tumors expressing α(v)β(3) integrins Ocampo-García, Blanca E.
2013
72-73 4 p. 481-487
7 p.
article
78 Detection of acute infection/inflammation with Tc-99m labeled intact polyvalent human IgG Wong, Dennis W.
1995
72-73 4 p. 513-519
7 p.
article
79 Determination of estrogen 3-sulfates in biological fluids of mammary tumor-bearing rats by radioimmunoassay Shimura, Noriko
1993
72-73 4 p. 493-501
9 p.
article
80 Determination of the target volume of HeLa cells treated with platinum-195m radiolabeled trans-diaminedichloroplatinum(II): a comparison with cis-diaminedichloroplatinum(II) Akaboshi, Mitsuhiko
1993
72-73 4 p. 389-393
5 p.
article
81 Development and evaluation of a radiobromine-labeled sigma ligand for tumor imaging Ogawa, Kazuma
2013
72-73 4 p. 445-450
6 p.
article
82 Development and validation of an anion-exchange HPLC method for the determination of fluoride content and radiochemical purity in [18F]NaF Li, Chang-Chin
2011
72-73 4 p. 605-612
8 p.
article
83 Development of a 111In-labeled peptide derivative targeting a chemokine receptor, CXCR4, for imaging tumors Hanaoka, Hirofumi
2006
72-73 4 p. 489-494
6 p.
article
84 Development of a nano-zirconia based 68Ge/68Ga generator for biomedical applications Chakravarty, Rubel
2011
72-73 4 p. 575-583
9 p.
article
85 Development of carbon-11 labeled acryl amides for selective PET imaging of active tissue transglutaminase van der Wildt, Berend
2016
72-73 4 p. 232-242
11 p.
article
86 Development of 111In-labeled tumor-associated antigen peptides for monitoring dendritic-cell-based vaccination Laverman, Peter
2006
72-73 4 p. 453-458
6 p.
article
87 Development of microwave-based automated nucleophilic [18F]fluorination system and its application to the production of [18F]flumazenil Mandap, Katheryn S.
2009
72-73 4 p. 403-409
7 p.
article
88 Development of the radiosynthesis of high-specific-activity 123I-NKJ64 Tavares, Adriana Alexandre S.
2011
72-73 4 p. 493-500
8 p.
article
89 Differences in binding of 99mTc-disintegrins to integrin αvβ3 on tumor and vascular cells Knight, Linda C.
2007
72-73 4 p. 371-381
11 p.
article
90 Different brain radioactivity curves in a PET study with [11C]β-CIT labelled in two different positions Lundkvist, Camilla
1999
72-73 4 p. 343-350
8 p.
article
91 2-(2′-((Dimethylamino)methyl)-4′-(3-[18F]fluoropropoxy)-phenylthio)benzenamine for positron emission tomography imaging of serotonin transporters Wang, Julie L.
2008
72-73 4 p. 447-458
12 p.
article
92 Discussion of targeting proteins in vivo: in vitro guidelines Eckelman, William C.
2006
72-73 4 p. 449-451
3 p.
article
93 Disposition of intravenous 123iodopentamidine in man Thomas, Simon H.L.
1997
72-73 4 p. 327-332
6 p.
article
94 Distribution of carbon-11 labeled methamphetamine and the effect of its chronic administration in mice Mizugaki, Michinao
1993
72-73 4 p. 487-492
6 p.
article
95 Dopamine transporter imaging in the aged rat: a [123I]FP-CIT SPECT study Niñerola-Baizán, Aida
2015
72-73 4 p. 395-398
4 p.
article
96 Double-stabilized neurotensin analogues as potential radiopharmaceuticals for NTR-positive tumors García-Garayoa, Elisa
2006
72-73 4 p. 495-503
9 p.
article
97 Dual receptor-targeting 99mTc-labeled Arg-Gly-Asp-conjugated Alpha-Melanocyte stimulating hormone hybrid peptides for human melanoma imaging Xu, Jingli
2015
72-73 4 p. 369-374
6 p.
article
98 Editorial Board 2014
72-73 4 p. IFC-
1 p.
article
99 Editorial Board 2015
72-73 4 p. IFC-
1 p.
article
100 Editorial Board 2016
72-73 4 p. IFC-
1 p.
article
101 Editorial Board 2013
72-73 4 p. IFC-
1 p.
article
102 Editorial Board 2011
72-73 4 p. IFC-
1 p.
article
103 Editorial Board 2012
72-73 4 p. IFC-
1 p.
article
104 Editorial Board 2009
72-73 4 p. IFC-
1 p.
article
105 Editorial Board 2010
72-73 4 p. IFC-
1 p.
article
106 Editorial board 2004
72-73 4 p. IFC-
1 p.
article
107 Effect of administration route on FES uptake into MCF-7 tumors Downer, Joanna B.
2001
72-73 4 p. 397-399
3 p.
article
108 Effect of iron deficiency anemia on the biodistribution of 99mTc radiopharmaceuticals Calmanovici, Gabriela P.
2006
72-73 4 p. 581-584
4 p.
article
109 Effect of p53 activation on cell growth, thymidine kinase-1 activity, and 3′-deoxy-3′fluorothymidine uptake Schwartz, Jeffrey L.
2004
72-73 4 p. 419-423
5 p.
article
110 Effect of reaction conditions on preparations of rhenium-188 hydroxyethylidene diphosphonate complexes Lin, Wan-Yu
1999
72-73 4 p. 455-459
5 p.
article
111 Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters Kilbourn, Michael R.
1996
72-73 4 p. 467-471
5 p.
article
112 Effects of ischemia-reperfusion injury on myocardial single pass extraction and retention of Cu-PTSM in perfused rat hearts: Comparison with 201Tl and 14C-iodoantipyrine Wada, Kouichi
1994
72-73 4 p. 613-617
5 p.
article
113 Efficacy of lentiviral-mediated transfection of hTSHR in poorly differentiated thyroid carcinoma cell line Cheng, Weiwei
2013
72-73 4 p. 576-580
5 p.
article
114 Electrophysiological Study, Biodistribution in Mice, and Preliminary PET Evaluation in a Rhesus Monkey of 1-Amino-3-[18F]fluoromethyl-5-methyl-adamantane (18F-MEM): A Potential Radioligand for Mapping the NMDA-Receptor Complex Samnick, Samuel
1998
72-73 4 p. 323-330
8 p.
article
115 Empirical Bayesian estimation in graphical analysis: a voxel-based approach for the determination of the volume of distribution in PET studies Zanderigo, Francesca
2010
72-73 4 p. 443-451
9 p.
article
116 Evaluation of adenosine preconditioning with 99mTc-His10-annexin V in a porcine model of myocardium ischemia and reperfusion injury: preliminary study Ye, Fei
2011
72-73 4 p. 567-574
8 p.
article
117 Evaluation of a direct method for technetium labeling intact and F(ab′)2 1A3, an anticolorectal monoclonal antibody Schwarz, Sally W.
1994
72-73 4 p. 619-626
8 p.
article
118 Evaluation of an automated double-synthesis module: efficiency and reliability of subsequent radiosyntheses of FHBG and FLT Niedermoser, Sabrina
2012
72-73 4 p. 586-592
7 p.
article
119 Evaluation of copper-labeled bifunctional chelate-albumin conjugates for blood pool imaging Anderson, Carolyn J.
1993
72-73 4 p. 461-467
7 p.
article
120 Evaluation of 4-[18F]fluorobenzoyl-FALGEA-NH2 as a positron emission tomography tracer for epidermal growth factor receptor mutation variant III imaging in cancer Denholt, Charlotte Lund
2011
72-73 4 p. 509-515
7 p.
article
121 Evaluation of 3-[18F]Fluoro-α-fluoromethyl-p-tyrosine as a tracer for striatal tyrosine hydroxylase activity Dejesus, O.T.
1994
72-73 4 p. 663-667
5 p.
article
122 Evaluation of 9-[(3-18F-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG) in vitro and in vivo as a probe for PET imaging of gene incorporation and expression in tumors Alauddin, Mian M
1999
72-73 4 p. 371-376
6 p.
article
123 Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model Wang, Hsin-Ell
2005
72-73 4 p. 367-375
9 p.
article
124 Evaluation of in vivo selective binding of [11C]doxepin to histamine H1 receptors in five animal species Ishiwata, Kiichi
2004
72-73 4 p. 493-502
10 p.
article
125 Evaluation of 99mTc-labeled photosan-3, a hematoporphyrin derivative, as a potential radiopharmaceutical for tumor scintigraphy Babbar, A.K
2000
72-73 4 p. 419-426
8 p.
article
126 Evaluation of [99mTc] liposomes as lymphoscintigraphic agents: comparison with [99mTc] sulfur colloid and [99mTc] human serum albumin Phillips, William T.
2001
72-73 4 p. 435-444
10 p.
article
127 Evaluation of (+)-p-[11C]methylvesamicol for mapping sigma1 receptors: a comparison with [11C]SA4503 Ishiwata, Kiichi
2006
72-73 4 p. 543-548
6 p.
article
128 Evaluation of radioselenium labeled selenomethionine, a potential tracer for brain protein synthesis by PET Bergmann, Ralf
1995
72-73 4 p. 475-481
7 p.
article
129 Evaluation of the antitumor effects of rilotumumab by PET imaging in a U-87 MG mouse xenograft model Rex, Karen
2013
72-73 4 p. 458-463
6 p.
article
130 Exploration of the Dopamine Transporter: In Vitro and In Vivo Characterization of a High-Affinity and High-Specificity Iodinated Tropane Derivative (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy- 3β-(4′-methylphenyl)nortropane (PE2I) Guilloteau, Denis
1998
72-73 4 p. 331-337
7 p.
article
131 Expression of hexokinase II and Glut-1 in untreated human breast cancer Brown, Raya S.
2002
72-73 4 p. 443-453
11 p.
article
132 Factors affecting 18 F FDOPA standardized uptake value in patients with primary brain tumors after treatment Chiaravalloti, Agostino
2015
72-73 4 p. 355-359
5 p.
article
133 FDG Accumulation and Tumor Biology Pauwels, E.K.J
1998
72-73 4 p. 317-322
6 p.
article
134 Feasibility of a novel positive feedback effect of 131I-promoted Bac-Egr1-hNIS expression in malignant glioma via baculovirus Guo, Rui
2011
72-73 4 p. 599-604
6 p.
article
135 [18F]FE@SUPPY and [18F]FE@SUPPY:2 — metabolic considerations Haeusler, Daniela
2010
72-73 4 p. 421-426
6 p.
article
136 [18F]fluoroalkyl analogues of the potent 5-HT1A antagonist WAY 100635: Radiosyntheses and in vivo evaluation Wilson, Alan A.
1996
72-73 4 p. 487-490
4 p.
article
137 [18F]fluoro-β-fluoromethylene-m-tyrosine derivatives show stereo, geometrical, and regio specificities as in vivo central dopaminergic probes in monkeys Huang, S.-C
1999
72-73 4 p. 365-370
6 p.
article
138 18F-fluoromethylcholine or 18F-fluoroethylcholine pet for prostate cancer imaging: which is better? A literature revision Evangelista, Laura
2015
72-73 4 p. 340-348
9 p.
article
139 18F-Labeling and evaluation of novel MDL 100907 derivatives as potential 5-HT2A antagonists for molecular imaging Debus, Fabian
2010
72-73 4 p. 487-495
9 p.
article
140 18F-Labelled metomidate analogues as adrenocortical imaging agents Erlandsson, Maria
2009
72-73 4 p. 435-445
11 p.
article
141 Fluorine-18-labelled NCQ 115, a selective dopamine D-2 receptor ligand. Preparation and positron emission tomography Halldin, Christer
1994
72-73 4 p. 627-631
5 p.
article
142 5-Fluoro-[β-11C]-L-tryptophan is a functional analogue of 5-hydroxy-[β-11C]-L-tryptophan in vitro but not in vivo Eriksson, Olof
2013
72-73 4 p. 567-575
9 p.
article
143 18F-nanobody for PET imaging of HER2 overexpressing tumors Xavier, Catarina
2016
72-73 4 p. 247-252
6 p.
article
144 [18F]N-4′-Fluorobenzyl-4-(3-bromophenyl) acetamide for imaging the sigma receptor status of tumors: comparison with [18F]FDG and [125I]IUDR Mach, R.H.
2001
72-73 4 p. 451-458
8 p.
article
145 Functional comparison of annexin V analogues labeled indirectly and directly with iodine-124 Dekker, Bronwen
2005
72-73 4 p. 403-413
11 p.
article
146 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers Persson, Morten
2012
72-73 4 p. 560-569
10 p.
article
147 Ganciclovir Uptake in Human Mammary Carcinoma Cells Expressing Herpes Simplex Virus Thymidine Kinase Haberkorn, Uwe
1998
72-73 4 p. 367-373
7 p.
article
148 Glucose and insulin variations in patients during the time course of a FDG-PET study and implications for the “glucose-corrected” SUV Hadi, Mohiuddin
2008
72-73 4 p. 441-445
5 p.
article
149 Guidebook for the treatment of accidental radionuclide contamination of workers Taylor, David M.
1993
72-73 4 p. 557-
1 p.
article
150 High purity production and potential applications of copper-60 and copper-61 McCarthy, Deborah W
1999
72-73 4 p. 351-358
8 p.
article
151 High-Yield Radiosynthesis and Preliminary In Vivo Evaluation of p-[18F]MPPF, a Fluoro Analog of WAY-100635 Le Bars, D
1998
72-73 4 p. 343-350
8 p.
article
152 High yield synthesis of [11C]-acetone through selective quenching of methyl lithium Studenov, Andrei R
1999
72-73 4 p. 431-435
5 p.
article
153 High-yield synthesis of the terminal 188Re≡N multiple bond from generator-produced [188ReO4]− Boschi, Alessandra
2003
72-73 4 p. 381-387
7 p.
article
154 Human Polyclonal Immunoglobulin Labelled with Technetium-99m via NHS-MAG3: A Comparison of Radiochemical Behavior and Biological Efficacy with Other Labelling Methods Gano, L
1998
72-73 4 p. 395-403
9 p.
article
155 Identification and quantitation of gaseous compounds of fluorine generated in [18F]F2 target systems Bishop, Allyson
1996
72-73 4 p. 391-405
15 p.
article
156 3-[123I]Iodo-L-α-methyl tyrosine transport into human fibroblasts and comparison with Ewing’s sarcoma cells Franzius, Christiane
2002
72-73 4 p. 483-490
8 p.
article
157 [125I]iomazenil binding in the brains of spontaneously epileptic rats: An ex vivo quantitative autoradiographic study Nagata, Tamotsu
1995
72-73 4 p. 445-449
5 p.
article
158 Imaging β-amyloid fibrils in Alzheimer's disease: a critical analysis through simulation of amyloid fibril polymerization Shoghi-Jadid, Kooresh
2005
72-73 4 p. 337-351
15 p.
article
159 Imaging apoptosis in vivo using 124I-annexin V and PET Keen, Heather G.
2005
72-73 4 p. 395-402
8 p.
article
160 Imaging Tc-99m-labeled FGF-1 targeting in rats Zinn, Kurt R
2000
72-73 4 p. 407-414
8 p.
article
161 Impact of 18F-fluoride PET-CT on implementing early treatment of painful bone metastases with Sm-153 EDTMP Storto, Giovanni
2013
72-73 4 p. 518-523
6 p.
article
162 Improved synthesis of 2′-deoxy-2′-[18F]-fluoro-1-β-d-arabinofuranosyl-5-iodouracil ([18F]-FIAU) Anderson, Harry
2010
72-73 4 p. 439-442
4 p.
article
163 Infection detection in mice using 99mTc-labeled HYNIC and N2S2 chelate conjugated to the antimicrobial peptide UBI 29-41 Welling, Mick M.
2004
72-73 4 p. 503-509
7 p.
article
164 Influence of cations on the complexation yield of DOTATATE with yttrium and lutetium: a perspective study for enhancing the 90Y and 177Lu labeling conditions Asti, Mattia
2012
72-73 4 p. 509-517
9 p.
article
165 Initial characterization of a PDE10A selective positron emission tomography tracer [11C]AMG 7980 in non-human primates Hwang, Dah-Ren
2014
72-73 4 p. 343-349
7 p.
article
166 Initial evaluation in healthy humans of [18F]DPA-714, a potential PET biomarker for neuroinflammation Arlicot, Nicolas
2012
72-73 4 p. 570-578
9 p.
article
167 In-site interaction evaluation of Tn density by inhibition/competition assays Robles, Ana
2010
72-73 4 p. 453-458
6 p.
article
168 Intracellular Metabolism of 99mTc-d,l-HMPAO In Vitro: A Basic Approach for Understanding the Hyperfixation Mechanism in Damaged Brain Fujibayashi, Yasuhisa
1998
72-73 4 p. 375-378
4 p.
article
169 Intratumoral injection with [188Re]rhenium sulfide suspension for treatment of transplanted human liver carcinoma in nude mice Junfeng, Yu
2000
72-73 4 p. 347-352
6 p.
article
170 Investigation of four 99mTc-labeled bacteriophages for infection-specific imaging Rusckowski, Mary
2008
72-73 4 p. 433-440
8 p.
article
171 Investigation of the pharmacokinetics of 3′-deoxy-3′-[18F]fluorothymidine uptake in the bone marrow before and early after initiation of chemoradiation therapy in head and neck cancer Menda, Yusuf
2010
72-73 4 p. 433-438
6 p.
article
172 Investigations of acetonitrile solvent cluster formation in supercritical carbon dioxide, and its impact on microscale syntheses of carbon-11-labeled radiotracers for PET Ferrieri, Richard A
1999
72-73 4 p. 443-454
12 p.
article
173 In vitro and in vivo evaluation of 177Lu- and 90Y-labeled E. coli heat-stable enterotoxin for specific targeting of uroguanylin receptors on human colon cancers Giblin, Michael F.
2006
72-73 4 p. 481-488
8 p.
article
174 In vitro and in vivo evaluation of novel ligands for radioimmunotherapy Chong, Hyun-Soon
2006
72-73 4 p. 459-467
9 p.
article
175 In vitro and in vivo evaluations of a radioiodinated thymidine phosphorylase inhibitor as a tumor diagnostic agent for angiogenic enzyme imaging Akizawa, Hiromichi
2010
72-73 4 p. 427-432
6 p.
article
176 In vivo binding of [18F]altanserin to rat brain 5HT2 receptors: A film and electronic autoradiographic study Biver, F.
1997
72-73 4 p. 357-360
4 p.
article
177 In vivo comparison of macrocyclic and acyclic ligands for radiolabeling of monoclonal antibodies with 177Lu for radioimmunotherapeutic applications Milenic, Diane E.
2002
72-73 4 p. 431-442
12 p.
article
178 In vivo dynamic distribution of 131I-glucagon-like peptide-1 (7–36) amide in the rat studied by gamma camera Hassan, Moustapha
1999
72-73 4 p. 413-420
8 p.
article
179 In vivo evaluation of a new 18F-labeled PET ligand, [18F]FEBU, for the imaging of I2-imidazoline receptors Kawamura, Kazunori
2015
72-73 4 p. 406-412
7 p.
article
180 In vivo evaluation of carbon-11-labelled non-sarcosine-based glycine transporter 1 inhibitors in mice and conscious monkeys Toyohara, Jun
2011
72-73 4 p. 517-527
11 p.
article
181 In vivo evaluation of [123I]-4-(2-(bis(4-fluorophenyl)methoxy)ethyl)-1-(4-iodobenzyl)piperidine, an iodinated SPECT tracer for imaging the P-gp transporter De Bruyne, Sylvie
2010
72-73 4 p. 469-477
9 p.
article
182 In vivo examination of 188Re(I)-tricarbonyl-labeled trastuzumab to target HER2-overexpressing breast cancer Chen, Kuo-Ting
2009
72-73 4 p. 355-361
7 p.
article
183 In vivo imaging and specific targeting of P-glycoprotein expression in multidrug resistant nude mice xenografts with [125I]MRK-16 monoclonal antibody Scott, Andrew M.
1995
72-73 4 p. 497-504
8 p.
article
184 In vivo metabolism of the technetium isonitrile complex [Tc(2-ethoxy-2-methyl-1-isocyanopropane)6]+ Barbarics, Eva
1994
72-73 4 p. 583-591
9 p.
article
185 In vivo studies of the SERT-selective [18F]FPBM and VMAT2-selective [18F]AV-133 radiotracers in a rat model of Parkinson's disease Wang, Julie L.
2010
72-73 4 p. 479-486
8 p.
article
186 131I-recombinant human EGF has antitumor effects against MCF-7 human breast cancer xenografts with low levels of EGFR Li, Yun Chun
2004
72-73 4 p. 435-440
6 p.
article
187 Kinetic analysis of FDG in rat liver: Effect of dietary intervention on arterial and portal vein input Rani, Sudheer D.
2013
72-73 4 p. 537-546
10 p.
article
188 Kinetic modelling of [123I]CNS 1261—a potential SPET tracer for the NMDA receptor Erlandsson, Kjell
2003
72-73 4 p. 441-454
14 p.
article
189 Labeling and in vivo evaluation of novel copper(II) dioxotetraazamacrocyclic complexes Cutler, Cathy S.
2000
72-73 4 p. 375-380
6 p.
article
190 Labeling, stability and biodistribution studies of 99mTc-cyclized Tyr3-octreotate derivatives Bigott-Hennkens, Heather M.
2011
72-73 4 p. 549-555
7 p.
article
191 Labelling small quantities of monoclonal antibodies and their F(ab′)2 fragments with technetium-99m Tesic, Milena
1995
72-73 4 p. 451-457
7 p.
article
192 Letter to editor Balayssac, David
2003
72-73 4 p. 455-
1 p.
article
193 Mechanism of nitrogen-13-labeled ammonia formation in a cryogenic water target Firouzbakht, Mahmoud L
1999
72-73 4 p. 437-441
5 p.
article
194 Melanoma imaging using 111In-, 86Y- and 68Ga-labeled CHX-A″-Re(Arg11)CCMSH Wei, Lihui
2009
72-73 4 p. 345-354
10 p.
article
195 Metabolic comparison of radiolabeled aniline- and phenol-phthaleins with 131I Avcıbaşı, Uğur
2008
72-73 4 p. 481-492
12 p.
article
196 Metabolism and autoradiographic evaluation of [18F]FE@CIT: a Comparison with [123I]β-CIT and [123I]FP-CIT Ettlinger, Dagmar E.
2008
72-73 4 p. 475-479
5 p.
article
197 Metal complexes of bleomycin: evaluation of [Rh-105]-bleomycin for use in targeted radiotherapy Brooks, R.C
1999
72-73 4 p. 421-430
10 p.
article
198 Method for stabilizing non carrier added 2-[18F]fluoromethyl-l-phenylalanine, a new tumour tracer, during radiosynthesis and radiopharmaceutical formulation Kersemans, Ken
2008
72-73 4 p. 425-432
8 p.
article
199 Monte Carlo-Assisted Voxel Source Kernel Method (MAVSK) for Internal Beta Dosimetry Liu, An
1998
72-73 4 p. 423-433
11 p.
article
200 99mTc labeled VIP analog: evaluation for imaging colorectal cancer Rao, P.S.
2001
72-73 4 p. 445-450
6 p.
article
201 99mTc-N, N′-bis(aminoethyl)propanediamine hexaacetic acid (BPHA): a glomerular filtration agent similar to 99mTc-DTPA Liu, Guozheng
2002
72-73 4 p. 399-404
6 p.
article
202 [99mTc]O2-AMD3100 as a SPECT tracer for CXCR4 receptor imaging Hartimath, Siddesh V.
2013
72-73 4 p. 507-517
11 p.
article
203 99mTc-pertechnetate uptake in hepatoma cells due to tissue-specific human sodium iodide symporter gene expression Chen, Libo
2006
72-73 4 p. 575-580
6 p.
article
204 [99mTc]teboroxime and [99mTc]Cl(DMG)3B2MP: Binding characteristics and metabolism of two [99mTc]BATOs in blood and tissues Rosenspire, Karen C.
1993
72-73 4 p. 395-400
6 p.
article
205 99m-Technetium-labelled peptide-HYNIC conjugates: effects of lipophilicity and stability on biodistribution Decristoforo, Clemens
1999
72-73 4 p. 389-396
8 p.
article
206 New automated synthesis of [18F]FP-CIT with base amount control affording high and stable radiochemical yield: a 1.5-year production report Lee, Sang Ju
2011
72-73 4 p. 593-597
5 p.
article
207 New radioiodinated carboxylic and hydroxamic matrix metalloproteinase inhibitor tracers as potential tumor imaging agents Oltenfreiter, Ruth
2004
72-73 4 p. 459-468
10 p.
article
208 N1′-fluoroethyl-naltrindole (BU97001) and N1′-fluoroethyl-(14-formylamino)-naltrindole (BU97018) potential δ-opioid receptor PET ligands Tyacke, Robin J.
2002
72-73 4 p. 455-462
8 p.
article
209 No-carrier-added synthesis of aliphatic and aromatic radioselenoethers via selenocyanates Blum, Till
2003
72-73 4 p. 361-367
7 p.
article
210 Noninvasive assessment of cell proliferation in ovarian cancer using [18F] 3′deoxy-3-fluorothymidine positron emission tomography/computed tomography imaging Richard, Scott D.
2011
72-73 4 p. 485-491
7 p.
article
211 Noninvasive visualization and quantification of tumor αVβ3 integrin expression using a novel positron emission tomography probe, 64Cu-cyclam-RAFT-c(-RGDfK-)4 Jin, Zhao-Hui
2011
72-73 4 p. 529-540
12 p.
article
212 Novel carbon-11 labeled 4-dimethylamino-but-2-enoic acid [4-(phenylamino)-quinazoline-6-yl]-amides: potential PET bioprobes for molecular imaging of EGFR-positive tumors Mishani, Eyal
2004
72-73 4 p. 469-476
8 p.
article
213 N-succinimidyl 3-[211At]astato-4-guanidinomethylbenzoate: an acylation agent for labeling internalizing antibodies with α-particle emitting 211At Vaidyanathan, Ganesan
2003
72-73 4 p. 351-359
9 p.
article
214 N-Succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate: Synthesis and potential utility for the radioiodination of monoclonal antibodies Garg, Pradeep K.
1993
72-73 4 p. 379-387
9 p.
article
215 Nucleophilic radiosynthesis of 2-[18F]fluoro-2-deoxy-d-galactose from Talose triflate and biodistribution in a porcine model Frisch, Kim
2011
72-73 4 p. 477-483
7 p.
article
216 Obituary of Prof. Stöcklin, Sydney, August 10, 2003 Coenen, Heinz H
2004
72-73 4 p. 531-
1 p.
article
217 One-step high-radiochemical-yield synthesis of [18F]FP-CIT using a protic solvent system Lee, Sang Ju
2007
72-73 4 p. 345-351
7 p.
article
218 Optimization of precursor synthesis, formulation and stability of 1′-[18 F]fluoroethyl-β-D-lactose ([18 F]FEL) for preclinical studies in detection of pancreatic cancer Paolillo, Vincenzo
2014
72-73 4 p. 364-370
7 p.
article
219 Palladium mediated 11C-cyanation and characterization in the non-human primate brain of the novel mGluR5 radioligand [11C]AZD9272 Andersson, Jan D.
2013
72-73 4 p. 547-553
7 p.
article
220 Perspective, the one most responsive to change Eckelman, William C.
2014
72-73 4 p. 297-298
2 p.
article
221 PET imaging detection of macrophages with a formyl peptide receptor antagonist Zhang, Yi
2015
72-73 4 p. 381-386
6 p.
article
222 PET Imaging of CRF1 with [11C]R121920 and [11C]DMP696: is the target of sufficient density? Sullivan, Gregory M.
2007
72-73 4 p. 353-361
9 p.
article
223 PET-pharmacokinetics of 18F-octreotide: A comparison with 67Ga-DFO and 86Y-DTPA-octreotide Wester, Hans-Jürgen
1997
72-73 4 p. 275-286
12 p.
article
224 Pharmacokinetics and biodistribution of radiolabelled idoxifene: Prospects for the use of PET in the evaluation of a novel antioestrogen for cancer therapy Young, H.
1995
72-73 4 p. 405-411
7 p.
article
225 Pharmacokinetics and metabolism of 2-[18F]fluoro-2-deoxy-d-glucose (FDG) in mammary tumors of antiestrogen-treated rats Haaparanta, Merja
1995
72-73 4 p. 483-489
7 p.
article
226 Pharmacokinetics of the thymidine analog 2′-Fluoro-5-[14C]-methyl-1-β-D-arabinofuranosyluracil ([14C]FMAU) in rat prostate tumor cells Bading, James R.
2000
72-73 4 p. 361-368
8 p.
article
227 Pharmacokinetics of the thymidine analog 2′-fluoro-5-methyl-1-β-d-arabinofuranosyluracil (FMAU) in tumor-bearing rats Bading, James R.
2004
72-73 4 p. 407-418
12 p.
article
228 Physiologically based pharmacokinetic modeling of 18F-SiFAlin-Asp3-PEG1-TATE in AR42J tumor bearing mice Maaß, Christian
2016
72-73 4 p. 243-246
4 p.
article
229 Pingyangmycin as a 99mTc carrier in tumor localization Huang, Tiangui
1995
72-73 4 p. 537-542
6 p.
article
230 Pm-149 DOTA bombesin analogs for potential radiotherapy Hu, Fang
2002
72-73 4 p. 423-430
8 p.
article
231 Positron emission tomography (PET) with 11C-5-hydroxytryptophan (5-HTP) in patients with metastatic hormone-refractory prostatic adenocarcinoma Kälkner, Karl-Mikael
1997
72-73 4 p. 319-325
7 p.
article
232 Positron-labeled antioxidant 6-deoxy-6-[18F]fluoro-l-ascorbic acid: Increased uptake in transient global ischemic rat brain Yamamoto, Fumihiko
1996
72-73 4 p. 479-486
8 p.
article
233 Potential 18F-labeled biomarkers for epidermal growth factor receptor tyrosine kinase Bonasera, Thomas A
2001
72-73 4 p. 359-374
16 p.
article
234 Preclinical evaluation of an 18F-labelled β1-adrenoceptor selective radioligand based on ICI 89,406 Law, Marilyn P.
2010
72-73 4 p. 517-526
10 p.
article
235 Preclinical evaluation of anti-HER2 Affibody molecules site-specifically labeled with 111In using a maleimido derivative of NODAGA Altai, Mohamed
2012
72-73 4 p. 518-529
12 p.
article
236 Preclinical studies of potential amyloid binding PET/SPECT ligands in Alzheimer's disease Svedberg, Marie M.
2012
72-73 4 p. 484-501
18 p.
article
237 Preferential uptake of zinc, manganese, and rubidium in rat brain tumor Tamano, Haruna
2002
72-73 4 p. 505-508
4 p.
article
238 Preliminary clinical study in patients with hemispatial neglect after stroke by neglect test battery and 99mTc-ECD single-photon emission computed tomography Yin, Yafu
2009
72-73 4 p. 467-475
9 p.
article
239 Preliminary in vivo and ex vivo evaluation of the 5-HT2A imaging probe [18F]MH.MZ Herth, Matthias M.
2009
72-73 4 p. 447-454
8 p.
article
240 Preliminary studies of acetylcholinesterase activity in the rat brain using N-phenylferrocenecarboxamide labelled by the technetium-99m Mejri, Najoua
2013
72-73 4 p. 561-566
6 p.
article
241 Preparation and biological evaluation of radiolabelled antibodies with selected carbohydrate modifications Qi, P.
1993
72-73 4 p. 453-459
7 p.
article
242 Preparation and evaluation of samarium (III) phosphate [153Sm] colloid (SMPC) for possible therapeutic use Prabhakar, G
2000
72-73 4 p. 353-356
4 p.
article
243 Preparation and in vitro evaluation of “no-carrier-added” 18F-labeled biotin Najafi, A.
1993
72-73 4 p. 401-405
5 p.
article
244 Preparation and in vivo evaluation of a novel stabilized linker for 211At labeling of protein Talanov, Vladimir S.
2006
72-73 4 p. 469-480
12 p.
article
245 Preparation and preliminary biological evaluation of [18F]NCQ-115: a new selective reversible dopamine D2 receptor ligand Najafi, A.
1993
72-73 4 p. 549-555
7 p.
article
246 Preparation and preliminary evaluation of 4-[211At]astato-N-piperidinoethyl benzamide Garg, Pradeep K.
1995
72-73 4 p. 467-473
7 p.
article
247 Preparation of a Pure 99mTc-F(ab′)2 radioimmunoconjugate by direct labeling methods Griffiths, Gary L.
1994
72-73 4 p. 649-655
7 p.
article
248 Preparation of 8-[3-(4-Fluorobenzoyl)-propyl]-1-(4-[123I]iodobenzoyl)-1,3,8-triazaspiro[4,5]decan-4-one: A novel selective serotonin 5-HT2 receptor agent Samnick, Samuel
1997
72-73 4 p. 295-303
9 p.
article
249 Preparation of 99mTc-TRODAT-1 with high labeling yield in boiling water bath: A new formulation Erfani, Mostafa
2014
72-73 4 p. 317-321
5 p.
article
250 Pretargeted tumour imaging with streptavidin immunoconjugates of monoclonal antibody CC49 and 111In-DTPA-biocytin Alvarez-Diez, Teresa M.
1996
72-73 4 p. 459-466
8 p.
article
251 Pre vivo, ex vivo and in vivo evaluations of [68Ga]-EDTMP Mitterhauser, Markus
2007
72-73 4 p. 391-397
7 p.
article
252 Production, automatic delivery and bolus injection of [15O]water for positron emission tomography studies Van Naemen, John
1996
72-73 4 p. 413-416
4 p.
article
253 Production of [18F]F2 using the 16O(3He,p)18F reaction Bishop, Allyson
1996
72-73 4 p. 385-389
5 p.
article
254 Production of high purity 94mTc for positron emission tomography studies Qaim, Syed M.
2000
72-73 4 p. 323-328
6 p.
article
255 Production of 89Zr via the 89Y(p,n)89Zr reaction in aqueous solution: Effect of solution composition on in-target chemistry Pandey, Mukesh K.
2014
72-73 4 p. 309-316
8 p.
article
256 Prognostic value of positron emission tomography-assessed tumor heterogeneity in patients with thyroid cancer undergoing treatment with radiopeptide therapy Lapa, Constantin
2015
72-73 4 p. 349-354
6 p.
article
257 Purification of radiolabeled monoclonal antibodies to angiotensin-converting enzyme significantly improves specificity and efficacy of its targeting into the lung Hiemisch, H.
1993
72-73 4 p. 435-441
7 p.
article
258 Radiation dosimetry of [18F](N-methyl)benperidol as determined by whole-body PET imaging of primates Moerlein, S.M.
1997
72-73 4 p. 311-318
8 p.
article
259 Radiobromination of anti-HER2/neu/ErbB-2 monoclonal antibody using the p-isothiocyanatobenzene derivative of the [76Br]undecahydro-bromo-7,8-dicarba-nido-undecaborate(1-) ion Winberg, Karl Johan
2004
72-73 4 p. 425-433
9 p.
article
260 Radiochemical and biological characteristics of 99mTc-UBI 29–41 for imaging of bacterial infections Welling, Mick M.
2002
72-73 4 p. 413-422
10 p.
article
261 Radio-copper-labeled Cu-ATSM: an indicator of quiescent but clonogenic cells under mild hypoxia in a Lewis lung carcinoma model Oh, Myungmi
2009
72-73 4 p. 419-426
8 p.
article
262 Radioiodinated (aminostyryl)pyridinium (ASP) dyes: New cell membrane probes for labeling mixed leukocytes and lymphocytes for diagnostic imaging Lambert, Carol
1996
72-73 4 p. 417-427
11 p.
article
263 Radioiodinated methylene blue for melanoma targeting: Chemical characterisation and tumour selectivity of labelled components Blower, Philip J.
1997
72-73 4 p. 305-310
6 p.
article
264 Radioiodinated 2-nitrobenzyl carbamates as bioreductive alkylating agents for tissue hypoxia Culbert, Paul A.
1993
72-73 4 p. 477-485
9 p.
article
265 Radioiodination and astatination of octreotide by conjugation labeling Vaidyanathan, Ganesan
2000
72-73 4 p. 329-337
9 p.
article
266 Radioiodination of glycoprotein-conjugated liposomes by using the Bolton-Hunter reagent and biodistribution in tumor-bearing mice Shimura, N.
2002
72-73 4 p. 491-496
6 p.
article
267 Radiolabeled antibodies in prostate cancer: A case study showing the effect of host immunity on antibody bio-distribution Vilhelmsson-Timmermand, Oskar
2015
72-73 4 p. 375-380
6 p.
article
268 Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies Faintuch, Bluma Linkowski
2008
72-73 4 p. 401-411
11 p.
article
269 Radiolabeled high affinity peptidomimetic antagonist selectively targets αvβ3 receptor-positive tumor in mice Jang, Beom-Su
2007
72-73 4 p. 363-370
8 p.
article
270 Radiolabeling of trastuzumab with 177Lu via DOTA, a new radiopharmaceutical for radioimmunotherapy of breast cancer Rasaneh, Samira
2009
72-73 4 p. 363-369
7 p.
article
271 Radiolabeling small RNA with technetium-99m for visualizing cellular delivery and mouse biodistribution Liu, Ning
2007
72-73 4 p. 399-404
6 p.
article
272 Radioligands for PET studies of central benzodiazepine receptors and PK (peripheral benzodiazepine) binding sites—current status Pike, V.W.
1993
72-73 4 p. 503-525
23 p.
article
273 Radionuclide imaging of small-cell lung cancer (SCLC) using 99mTc-labeled neurotensin peptide 8–13 Zhang, Kaijun
2006
72-73 4 p. 505-512
8 p.
article
274 Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-d-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer Wuest, Melinda
2011
72-73 4 p. 461-475
15 p.
article
275 Radiosynthesis and biodistribution of the S-[18F]fluoroethyl analog of McN5652 Suehiro, Makiko
1996
72-73 4 p. 407-412
6 p.
article
276 Radiosynthesis and biological evaluation of alpha-[F-18]fluoromethyl phenylalanine for brain tumor imaging Huang, Chaofeng
2013
72-73 4 p. 498-506
9 p.
article
277 Radiosynthesis and evaluation of two novel 123I-labeled 2-methyl-4-nitroimidazole derivatives as potential infection imaging agents Rossouw, Daniel D.
2005
72-73 4 p. 385-394
10 p.
article
278 Radiosynthesis and in vitro stability evaluation of various radioiodine-labelled β-iodoalkylether prosthetic groups linked to model compounds Rossouw, D.D.
2003
72-73 4 p. 373-380
8 p.
article
279 Radiosynthesis and in vivo evaluation of [11C]-labelled pyrrole-2-carboxamide derivates as novel radioligands for PET imaging of monoamine oxidase A De Bruyne, Sylvie
2010
72-73 4 p. 459-467
9 p.
article
280 Radiosynthesis and in vivo evaluation of fluorinated huprine derivates as PET radiotracers of acetylcholinesterase Da Costa Branquinho, Emilie
2013
72-73 4 p. 554-560
7 p.
article
281 Radiosynthesis and in vivo evaluation of the pseudopeptide δ-opioid antagonist [125I]-ITIPP(ψ) Collier, T.L
2001
72-73 4 p. 375-381
7 p.
article
282 Radiosynthesis and Quality Assurance of 5-[124I]Iodo-2′-deoxyuridine for Functional PET Imaging of Cell Proliferation Guenther, Ilonka
1998
72-73 4 p. 359-365
7 p.
article
283 Rational development of radiopharmaceuticals for HIV-1 Lau, Chuen-Yen
2014
72-73 4 p. 299-308
10 p.
article
284 Receptor binding radiotracers for the angiotensin II receptor: Radioiodinated [Sar13,Ile8] angiotensin II Gibson, Raymond E.
1994
72-73 4 p. 593-600
8 p.
article
285 Rhemium-186-monoaminemonoamidedithiol-conjugated bisphosphonate derivatives for bone pain palliation Ogawa, Kazuma
2006
72-73 4 p. 513-520
8 p.
article
286 Safety and efficacy of radioimmunotherapy (RIT) in treatment of non-Hodgkin's lymphoma in the community setting Hadid, Tarik
2016
72-73 4 p. 227-231
5 p.
article
287 ScVEGF-PEG-HBED-CC and scVEGF-PEG-NOTA conjugates: comparison of easy-to-label recombinant proteins for [68Ga]PET imaging of VEGF receptors in angiogenic vasculature Eder, Matthias
2010
72-73 4 p. 405-412
8 p.
article
288 Sensitivity of [11C]N-methylpyrrolidinyl benzilate ([11C]NMPYB) to endogenous acetylcholine: PET imaging vs tissue sampling methods Ma, Bing
2004
72-73 4 p. 393-397
5 p.
article
289 Sequence-specific binding and cleavage of duplex DNA by a radioiodinated, intercalator-linked, triplex-forming oligonucleotide Orson, Frank M.
1996
72-73 4 p. 519-524
6 p.
article
290 Sigma1 and dopamine D2 receptor occupancy in the mouse brain after a single administration of haloperidol and two dopamine D2-like receptor ligands Ishiwata, Kiichi
2003
72-73 4 p. 429-434
6 p.
article
291 Significance of 111In-DTPA chelate in renal radioactivity levels of 111In-DTPA-conjugated peptides Akizawa, Hiromichi
2001
72-73 4 p. 459-468
10 p.
article
292 Similarities in the Biodistribution of Iodine-Labeled Anti-Tac Single-Chain Disulfide-Stabilized Fv Fragment and Anti-Tac Disulfide-Stabilized Fv Fragment Kobayashi, Hisataka
1998
72-73 4 p. 387-393
7 p.
article
293 Simple preparation and purification of ethanol-free solutions of 3′-deoxy-3′-[18F]fluorothymidine by means of disposable solid-phase extraction cartridges Pascali, Claudio
2012
72-73 4 p. 540-550
11 p.
article
294 Sterically stabilized liposomes as a carrier for α-emitting radium and actinium radionuclides Henriksen, Gjermund
2004
72-73 4 p. 441-449
9 p.
article
295 Strategy for improved [11C]DAA1106 radiosynthesis and in vivo peripheral benzodiazepine receptor imaging using microPET, evaluation of [11C]DAA1106 Probst, Katrin C.
2007
72-73 4 p. 439-446
8 p.
article
296 Studies with [11C]alprazolam: an agonist for the benzodiazepine receptor Dobbs, Frank R.
1995
72-73 4 p. 459-466
8 p.
article
297 3′-Sulfonylesters of 2,5′-anhydro-1-(2-deoxy-β-d-threo-pentofuranosyl)thymine as precursors for the synthesis of [18F]FLT: syntheses and radiofluorination trials Windhorst, Albert D.
2008
72-73 4 p. 413-423
11 p.
article
298 Synthesis and biodistribution of fluorine-18-labeled fluorocyclofenils for imaging the estrogen receptor Seo, Jai Woong
2007
72-73 4 p. 383-390
8 p.
article
299 Synthesis and biological evaluation in Mice of (2-[11C]methoxy)-6′,7′-dihydrorotenol, a second generation rotenoid for marking mitochondrial complex I activity Charalambous, A.
1995
72-73 4 p. 491-496
6 p.
article
300 Synthesis and biological evaluation of a fluorine-18 labeled estrogen receptor-α selective ligand: [18F] propyl pyrazole triol Vijaykumar, Dange
2003
72-73 4 p. 397-404
8 p.
article
301 Synthesis and biological evaluation of carbon-11- and fluorine-18-labeled 2-oxoquinoline derivatives for type 2 cannabinoid receptor positron emission tomography imaging Evens, Nele
2009
72-73 4 p. 455-465
11 p.
article
302 Synthesis and biological evaluation of [11C]AZ12504948; a novel tracer for imaging of glucokinase in pancreas and liver Jahan, M.
2015
72-73 4 p. 387-394
8 p.
article
303 Synthesis and biological evaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7-14)NH2], a novel bivalent targeting vector having affinity for two distinct biomarkers (GRPr/PSMA) of prostate cancer Bandari, Rajendra Prasad
2014
72-73 4 p. 355-363
9 p.
article
304 Synthesis and biological evaluation of (E)-3-styrylpyridine derivatives as amyloid imaging agents for Alzheimer's disease Ono, Masahiro
2005
72-73 4 p. 329-335
7 p.
article
305 Synthesis and biological evaluation of radioiodinated N-2-(4-piperidyl)ethyl benzamides Efange, S.M.N.
1993
72-73 4 p. 527-538
12 p.
article
306 Synthesis and biological evaluation of radioiodinated phospholipid ether analogs Rampy, M.A.
1995
72-73 4 p. 505-512
8 p.
article
307 Synthesis and biological evaluation of technetium(III) mixed-ligand complexes with high affinity for the cerebral 5-HT1A receptor and the alpha1-adrenergic receptor Drews, A
2002
72-73 4 p. 389-398
10 p.
article
308 Synthesis and Characterization of a 11C-Labelled Derivative of S12968: An Attempt to Image In Vivo Brain Calcium Channels Dollé, Frédéric
1998
72-73 4 p. 339-342
4 p.
article
309 Synthesis and evaluation of a macrocyclic bifunctional chelating agent for use with bismuth radionuclides Garmestani, K
2001
72-73 4 p. 409-418
10 p.
article
310 Synthesis and evaluation of a new class of technetium-99m monocationic radiotracers from dithienyldiazalkanes Goomer, N.C.
1994
72-73 4 p. 657-662
6 p.
article
311 Synthesis and evaluation of 3-(4-chlorobenzyl)-8-[11C]methoxy-1,2,3,4-tetrahydrochromeno[3,4-c]pyridin-5-one: a PET tracer for imaging sigma1 receptors Zhang, Ming-Rong
2002
72-73 4 p. 469-476
8 p.
article
312 Synthesis and evaluation of 1-[11C]methyl-4-aryl-piperazinium salts as myocardial imaging agents Elmaleh, D.R.
1993
72-73 4 p. 427-433
7 p.
article
313 Synthesis and evaluation of 6-[18F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine as a PET tracer for nicotinic acetylcholine receptors Ding, Y.-S
2000
72-73 4 p. 381-389
9 p.
article
314 Synthesis and evaluation of [18F] labeled benzamides: High affinity sigma receptor ligands for PET imaging Dence, Carmen S.
1997
72-73 4 p. 333-340
8 p.
article
315 Synthesis and evaluation of fluorine-18 labeled glyburide analogs as β-cell imaging agents Schmitz, A
2004
72-73 4 p. 483-491
9 p.
article
316 Synthesis and evaluation of two novel 2-nitroimidazole derivatives as potential PET radioligands for tumor imaging Zha, Zhihao
2011
72-73 4 p. 501-508
8 p.
article
317 Synthesis and in vitro examination of [124I]-, [125I]- and [131I]-2-(4-iodophenylamino) pyrido[2,3-d]pyrimidin-7-one radiolabeled Abl kinase inhibitors Veach, Darren R.
2005
72-73 4 p. 313-321
9 p.
article
318 Synthesis and in vitro/in vivo evaluation of 99mTc-labeled folate conjugates for folate receptor imaging Lu, Jie
2011
72-73 4 p. 557-565
9 p.
article
319 Synthesis and in vivo distribution of no-carrier-added N(ω)-nitro-l-arginine [11C]methyl ester, a nitric oxide synthase inhibitor Roeda, Dirk
1996
72-73 4 p. 509-512
4 p.
article
320 Synthesis and in vivo evaluation of [11C]zolpidem, an imidazopyridine with agonist properties at central benzodiazepine receptors Dumont, Filip
2003
72-73 4 p. 435-439
5 p.
article
321 Synthesis and in vivo evaluation of (E)-N-[11C]Methyl-4- (3-pyridinyl)-3-butene-1-amine ([11C]metanicotine) as a nicotinic receptor radioligand Brown-Proctor, Clive
2000
72-73 4 p. 415-418
4 p.
article
322 Synthesis and in vivo evaluation of [O-methyl-11C](2R,4R)-4-hydroxy-2-[2-[2-[2-(3-methoxy)phenyl]ethyl]phenoxy]ethyl-1-methylpyrrolidine as a 5-HT2A receptor PET ligand Kumar, J.S. Dileep
2006
72-73 4 p. 565-574
10 p.
article
323 Synthesis and in vivo evaluation of 201Tl(III)–DOTA complexes for applications in SPECT imaging Hijnen, Nicole M.
2011
72-73 4 p. 585-592
8 p.
article
324 Synthesis and pharmacological evaluation of a new series of radiolabeled ligands for 5-HT7 receptor PET neuroimaging Colomb, Julie
2014
72-73 4 p. 330-337
8 p.
article
325 Synthesis and pharmacological evaluation of 11C-labeled piperazine derivative as a PET probe for sigma-2 receptor imaging Selivanova, Svetlana V.
2015
72-73 4 p. 399-405
7 p.
article
326 Synthesis and preclinical evaluation of [11C]D617, a metabolite of (R)-[11C]verapamil Verbeek, Joost
2012
72-73 4 p. 530-539
10 p.
article
327 Synthesis and preliminary biological evaluation of radiolabeled O6-benzylguanine derivatives, new potential PET imaging agents for the DNA repair protein O6-alkylguanine-DNA alkyltransferase in breast cancer Zheng, Qi-Huang
2003
72-73 4 p. 405-415
11 p.
article
328 Synthesis and preliminary evaluation of [18F]FEtP4A, a promising PET tracer for mapping acetylcholinesterase in vivo Zhang, Ming-Rong
2002
72-73 4 p. 463-468
6 p.
article
329 Synthesis and preliminary evaluation of [18F]-labeled 2-oxoquinoline derivatives for PET imaging of cannabinoid CB2 receptor Turkman, Nashaat
2012
72-73 4 p. 593-600
8 p.
article
330 Synthesis and radioiodination of a nido-1,2-carboranyl derivative of 2-nitroimidazole Wilbur, D.Scott
1994
72-73 4 p. 601-611
11 p.
article
331 Synthesis, biological and autoradiographic evaluation of a novel Tc-99m radioligand derived from WAY 100635 with high affinity for the 5-HT1A receptor and the alpha1-adrenergic receptor Heimbold, I.
2002
72-73 4 p. 375-387
13 p.
article
332 Synthesis, 11C labeling and biological properties of derivatives of the tyrphostin AG957 Ackermann, Uwe
2005
72-73 4 p. 323-328
6 p.
article
333 Synthesis, enantiomeric resolution, F-18 labeling and biodistribution of reboxetine analogs: promising radioligands for imaging the norepinephrine transporter with positron emission tomography Lin, Kuo-Shyan
2005
72-73 4 p. 415-422
8 p.
article
334 Synthesis, Estrogen Receptor Binding, and Tissue Distribution of a New Iodovinylestradiol Derivative (17α,20E)-21-[123I]Iodo-11β-Nitrato-19-Norpregna-1,3,5(10),20-Tetraene-3,17-Diol (E-[123I]NIVE) Rijks, Leonie J.M.
1998
72-73 4 p. 411-421
11 p.
article
335 Synthesis, in vitro binding and biodistribution in B16 melanoma-bearing mice of new iodine-125 spermidine benzamide derivatives Moreau, Marie-France
2005
72-73 4 p. 377-384
8 p.
article
336 Synthesis, in vitro pharmacologic characterization, and preclinical evaluation of N-[2-(1′-piperidinyl)ethyl]-3-[125I]iodo-4-methoxybenzamide (P[125I]MBA) for imaging breast cancer John, Christy S
1999
72-73 4 p. 377-382
6 p.
article
337 Synthesis of a new bisphosphonic acid ligand (SEDP) and preparation of a 188Re-(Sn)SEDP bone seeking radiotracer Lisic, Edward C
2001
72-73 4 p. 419-424
6 p.
article
338 Synthesis of a nonpeptide carbon-11 labeled substance P antagonist for PET studies Del Rosario, Renato B.
1993
72-73 4 p. 545-547
3 p.
article
339 Synthesis of a novel class of nitrido Tc-99m radiopharmaceuticals with phosphino-thiol ligands showing transient heart uptake Bolzati, Cristina
2000
72-73 4 p. 369-374
6 p.
article
340 Synthesis of carbon-11- and fluorine-18-labeled 1-methyl-4-piperidyl-4′-fluorobenzoate and their biodistribution in mice Bormans, G.
1996
72-73 4 p. 513-517
5 p.
article
341 Synthesis of [11C]dapoxetine · HCl, a serotonin re-uptake inhibitor: Biodistribution in rat and preliminary PET imaging in the monkey Livni, E.
1994
72-73 4 p. 669-675
7 p.
article
342 Synthesis of 2′-deoxy-2′-[18F]fluoro-5-bromo-1-β-D-arabinofuranosyluracil ([18F]-FBAU) and 2′-deoxy-2′-[18F]fluoro-5-chloro-1-β-D-arabinofuranosyl-uracil ([18F]-FCAU), and their biological evaluation as markers for gene expression Alauddin, Mian M.
2004
72-73 4 p. 399-405
7 p.
article
343 Synthesis of 2-[18F]Fluoro-2-deoxy-l-dlucose and positron emission tomography studies in monkeys Meng, Jean
1994
72-73 4 p. 633-640
8 p.
article
344 Synthesis of oncological [11C]radiopharmaceuticals for clinical PET Lodi, Filippo
2012
72-73 4 p. 447-460
14 p.
article
345 Synthesis of stereo (R and S) and geometric (E and Z) isomers of [18F]fluoro-β-fluoromethylene-m-tyrosine derivatives: in vivo probes of central dopaminergic function Lacan, Goran
1999
72-73 4 p. 359-363
5 p.
article
346 Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats Shah, Farah
1994
72-73 4 p. 573-581
9 p.
article
347 Synthesis, purification and biodistribution of 205Bi-DOTMP, visualizing bone deposition patterns with autoradiography Hassfjell, Sindre
2001
72-73 4 p. 425-433
9 p.
article
348 Synthesis, purification, and in vitro stability of 211At- and 125I-labeled amidobisphosphonates Murud, Kristin M
1999
72-73 4 p. 397-403
7 p.
article
349 Synthesis, radioiodination, and biodistribution of some nido- and closo-monocarbon carborane derivatives Wilbur, D.Scott
2004
72-73 4 p. 523-530
8 p.
article
350 Synthesis, radiolabeling, biodistribution and fluorescent imaging of histidine-coupled hematoporphyrin Liu, Yupeng
2012
72-73 4 p. 579-585
7 p.
article
351 Table of Contents 2014
72-73 4 p. IBC-
1 p.
article
352 Table of Contents 2015
72-73 4 p. IBC-
1 p.
article
353 Table of Contents 2016
72-73 4 p. IBC-
1 p.
article
354 Table of Contents 2013
72-73 4 p. IBC-
1 p.
article
355 Table of Contents 2011
72-73 4 p. IBC-
1 p.
article
356 Table of Contents 2012
72-73 4 p. IBC-
1 p.
article
357 Table of Contents 2007
72-73 4 p. IBC-
1 p.
article
358 Table of Contents 2009
72-73 4 p. IBC-
1 p.
article
359 Table of Contents 2006
72-73 4 p. VI-
1 p.
article
360 Targeting of renal carcinoma with 67/64Cu-labeled anti-L1-CAM antibody chCE7: selection of copper ligands and PET imaging Zimmermann, Kurt
2003
72-73 4 p. 417-427
11 p.
article
361 Technetium-99m IgG immunodetection of acute appendicitis in rats Wong, Dennis W.
1996
72-73 4 p. 473-478
6 p.
article
362 Technetium-99m labeled 1-(4-fluorobenzyl)-4-(2-mercapto-2-methyl-4-azapentyl)-4-(2-mercapto-2-methylpropylamino)-piperidine and iodine-123 metaiodobenzylguanidine for studying cardiac adrenergic function: a comparison of the uptake characteristics in vascular smooth muscle cells and neonatal cardiac myocytes, and an investigation in rats Samnick, Samuel
2004
72-73 4 p. 511-522
12 p.
article
363 Technetium-99m labeled somatostatin and analogs: Synthesis, characterization and in vivo evaluation Amartey, John K.
1993
72-73 4 p. 539-543
5 p.
article
364 Technetium-99m labeling anti-amastigote polyclonal antibodies of Leishmania amazonensis Araujo, J.G.V.C.
2002
72-73 4 p. 405-411
7 p.
article
365 Technetium(v) and rhenium(v) complexes for 5-HT2A serotonin receptor binding: Structure-affinity considerations Johannsen, B.
1996
72-73 4 p. 429-438
10 p.
article
366 The chemical nature, purity and stability of 99mTc-N-(2,6-diethyl-3-iodo-phenylcarbamoylmethyl)-iminodiacetic acid Lundberg, Parvin Shambayati
1995
72-73 4 p. 521-525
5 p.
article
367 The development of 99mTc-analog of Cu-DTS as an agent for imaging hypoxia Horiuchi, K
2000
72-73 4 p. 391-399
9 p.
article
368 The effect of molecular weight on nonspecific accumulation of 99mT-labeled proteins in inflammatory foci Rennen, Huub J.J.M
2001
72-73 4 p. 401-408
8 p.
article
369 The effect of PPAR-γ agonist on 18F-FDG uptake in tumor and macrophages and tumor cells Kim, Se-Lim
2009
72-73 4 p. 427-433
7 p.
article
370 The effects of clinically relevant hyperthermic temperatures on the kinetic binding parameters of a monoclonal antibody Hauck, Marlene L.
1996
72-73 4 p. 551-557
7 p.
article
371 The fate of MAb-targeted Cd125m Te/ZnS nanoparticles in vivo Kennel, Stephen J.
2008
72-73 4 p. 501-514
14 p.
article
372 The impact of weakly bound 89Zr on preclinical studies: Non-specific accumulation in solid tumors and aspergillus infection Severin, Gregory W.
2015
72-73 4 p. 360-368
9 p.
article
373 The interaction among glucose transport, hexokinase, and glucose-6-phosphatase with respect to 3H-2-deoxyglucose retention in murine tumor models Nelson, Carol A.
1996
72-73 4 p. 533-541
9 p.
article
374 The serotonin transporter in rhesus monkey brain: comparison of DASB and citalopram binding sites Zeng, Zhizhen
2006
72-73 4 p. 555-563
9 p.
article
375 The use of electronic autoradiography in radiopharmacy Decristoforo, C.
1997
72-73 4 p. 361-365
5 p.
article
376 Toxicity, Mutagenicity, and Behavioral Effects of β-CIT, a Ligand for Dopamine Transporter Exploration by SPECT Emond, P
1998
72-73 4 p. 405-409
5 p.
article
377 Transcellular transport of 4-iodo-L-meta-tyrosine via system L across monolayers of kidney epithelial cell line LLC-PK1 Shikano, Naoto
2004
72-73 4 p. 477-482
6 p.
article
378 Transfer of 131I and fluoresceinyl sialic acid derivatives into the oligosaccharide chains of IgG: a new method for site-specific labeling of antibodies Schwarz, U
1999
72-73 4 p. 383-388
6 p.
article
379 Transport mechanisms of hepatic uptake and bile excretion in clinical hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan Kobayashi, Masato
2014
72-73 4 p. 338-342
5 p.
article
380 Tumor imaging with technetium-99m-DTPA encapsulated in RES-avoiding liposomes Oku, Naoto
1993
72-73 4 p. 407-412
6 p.
article
381 Tumor resection cavity administered iodine-131-labeled antitenascin 81C6 radioimmunotherapy in patients with malignant glioma: neuropathology aspects McLendon, Roger E.
2007
72-73 4 p. 405-413
9 p.
article
382 Tumor targeting and pharmacokinetics of unmodified and modified F(ab)2 fragments of an anti-CEA murine monoclonal antibody (Immu-14) Siddiqui, Abrar
1995
72-73 4 p. 425-435
11 p.
article
383 Tumour imaging by Positron Emission Tomography using fluorinase generated 5-[18F]fluoro-5-deoxyribose as a novel tracer Dall'Angelo, Sergio
2013
72-73 4 p. 464-470
7 p.
article
384 Uptake of radiolabeled morphiceptin and its analogs by experimental mammary adenocarcinoma: in vitro and in vivo studies Mirowski, M.
2004
72-73 4 p. 451-457
7 p.
article
385 Uptake of 169Yb complexes in normal and tumour cells: Influence of ligand and metabolic cell activity and stability of cellular association Kampf, G.
1997
72-73 4 p. 349-355
7 p.
article
386 Use of a column-switching high-performance liquid chromatography method to assess the presence of specific binding of (R)- and (S)-[11C]rolipram and their labeled metabolites to the phosphodiesterase-4 enzyme in rat plasma and tissues Kenk, Miran
2008
72-73 4 p. 515-521
7 p.
article
387 Validation of an amino-acid-based radionuclide therapy plus external beam radiotherapy in heterotopic glioblastoma models Israel, Ina
2011
72-73 4 p. 451-460
10 p.
article
388 Validation of an 18F-labeled biphenylalkyne as a positron emission tomography imaging agent for β-amyloid plaques Wey, Shiaw-Pyng
2009
72-73 4 p. 411-417
7 p.
article
389 Visualizing inflammation activity in rheumatoid arthritis with Tc-99 m Anti-CD4-mAb fragment scintigraphy Steinhoff, K.
2014
72-73 4 p. 350-354
5 p.
article
390 48V radionuclidic impurity in product streams from liquid cyclotron targets with titanium windows Mazza, Samuel M.
1994
72-73 4 p. 677-679
3 p.
article
391 Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent — a pilot study Lin, Kun-Ju
2010
72-73 4 p. 497-508
12 p.
article
392 Whole-body biodistribution and radiation dosimetry in monkeys and humans of the phosphodiesterase 4 radioligand [11C](R)-rolipram: comparison of two-dimensional planar, bisected and quadrisected image analyses Sprague, David R.
2008
72-73 4 p. 493-500
8 p.
article
393 Whole-body distribution and radiation dosimetry of the dopamine transporter radioligand [11C]PE2I in healthy volunteers Ribeiro, Maria-João
2007
72-73 4 p. 465-470
6 p.
article
394 175Yb-labeled hydroxyapatite: a potential agent for use in radiation synovectomy of small joints Chakraborty, Sudipta
2006
72-73 4 p. 585-591
7 p.
article
395 Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas Bhattacharyya, Sibaprasad
2013
72-73 4 p. 451-457
7 p.
article
                             395 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands